vascular dementia: A degenerative vascular disorder affecting the brain. It is caused by the blockage of the blood supply to the brain. It is manifested with decline of memory and cognitive functions.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
203 |
4. Check minimum number of eventsNone |
203 |
5. Include endpointsNone |
203 |
6. Filter based on genotype QC (FinnGen only) |
203 |
Control definitions (FinnGen only)
- Control exclude
- F5_DEMENTIA, G6_ALZHEIMER, G6_AD_WIDE
Extra metadata
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- F01
- Name in latin
- Alia dementia vascularis specificata
Similar endpoints
↥List of similar endpoints to
Vascular dementia (other)
based on the number of shared cases.
Similar with more cases:
- Vascular dementia
- Any dementia
- Any dementia, excluding more controls
- Dementia
- Dementia, including avohilmo
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 2901 | 1663 | 1210 |
| Only index persons | 2238 | 1308 | 930 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.04 | 0.05 | 0.03 |
| Only index persons | 0.04 | 0.05 | 0.04 |
| Median age at first event (years) | |||
| Whole population | 82.87 | 84.43 | 80.83 |
| Only index persons | 83.63 | 85.02 | 81.66 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 203 | 77 | 126 |
| Unadjusted period prevalence (%) | 0.04 | 0.03 | 0.06 |
| Median age at first event (years) | 82.14 | 82.68 | 81.81 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 166
- Matched controls
- 1660
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
F01.80
ICD-10 Finland
Other specified vascular dementia without additional symptoms
+∞
57.7
52
*
F01.8
ICD-10 Finland
Other vascular dementia
742.4
56.0
52
*
F01.9
ICD-10 Finland
Vascular dementia, unspecified
324.7
48.8
47
*
N06DX01
ATC
memantine; oral
95.7
40.2
43
6
N05AX08
ATC
risperidone; systemic
19.4
38.5
61
48
F01.89
ICD-10 Finland
Other specified vascular dementia without information on additional symptoms
+∞
35.7
33
*
F03
ICD-10 Finland
Unspecified dementia
45.7
32.3
39
11
F01.84
ICD-10 Finland
Other specified vascular dementia other mixed symptoms of mixed type
278.4
24.3
24
*
N06DA04
ATC
galantamine; oral
59.6
18.4
21
*
N05AH04
ATC
quetiapine; oral
7.0
17.3
46
86
G30.9
ICD-10 Finland
Alzheimer disease, unspecified
+∞
17.0
16
*
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
5.6
16.4
53
127
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
7.6
16.0
39
64
F01.81
ICD-10 Finland
Other specified vascular dementia has other additional symptoms, mainly paranoidism
+∞
15.9
15
*
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
4.0
15.6
89
374
N06DA02
ATC
donepezil; oral
30.3
14.6
19
7
R41.0
ICD-10 Finland
Disorientation, unspecified
12.6
14.6
26
24
R53
ICD-10 Finland
Malaise and fatigue
4.2
14.3
65
219
G30.1
ICD-10 Finland
Alzheimer disease with late onset
33.3
14.2
18
6
P20
ICPC
Memory disturbance
4.9
14.1
52
142
A28
ICPC
Limited function/disability NOS
4.0
13.3
65
231
G30.8
ICD-10 Finland
Other Alzheimer disease
140.1
12.6
13
*
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
3.8
11.4
56
196
SPAT1053
SPAT
Memory test
3.6
11.4
62
234
L28
ICPC
Limited function/disability (L)
3.6
11.0
59
221
AA1AD
NOMESCO Finland
CT of head and brain
3.3
10.9
70
300
307
Kela drug reimbursment
Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease
+∞
10.5
10
*
N06AX11
ATC
mirtazapine; oral
3.2
10.1
68
299
N03AG01
ATC
valproic acid; systemic, rectal
8.4
9.8
21
28
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
3.2
9.6
61
256
N06DA03
ATC
rivastigmine; oral, transdermal
105.7
9.5
10
*
F01
ICD-10 Finland
Vascular dementia
105.7
9.5
10
*
F01.29
ICD-10 Finland
Subcortical vascular dementia without information on additional symptoms
+∞
9.5
9
*
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
3.5
9.0
47
168
B01AC30
ATC
platelet aggregation inhibitors excl. heparin - combinations
4.0
8.7
36
107
SPAT1216
SPAT
Assessment of functional ability
3.2
8.7
53
213
F05.9
ICD-10 Finland
Delirium, unspecified
12.6
8.2
14
12
SPAT1234
SPAT
Support of social functional capacity
5.0
8.2
26
59
R56.8
ICD-10 Finland
Other and unspecified convulsions
10.8
7.7
14
14
N06AB10
ATC
escitalopram; oral
3.9
7.6
32
96
N05AH03
ATC
olanzapine; systemic
7.9
7.4
16
22
F01.83
ICD-10 Finland
Other specified vascular dementia other additional symptoms, mainly depression
+∞
7.3
7
*
G40.9
ICD-10 Finland
Epilepsy, unspecified
8.6
7.3
15
19
N06AB04
ATC
citalopram; systemic
3.0
7.2
46
187
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
5.7
7.2
20
39
SPAT1222
SPAT
Counselling/guidance promoting independent living
2.9
7.0
48
205
F01.20
ICD-10 Finland
Subcortical vascular dementia without additional symptoms
41.8
6.8
8
*
F05.1
ICD-10 Finland
Delirium superimposed on dementia
41.8
6.8
8
*
P70
ICPC
Dementia
23.6
6.7
9
*
SPAT1226
SPAT
Implementation of occupational therapy rehabilitation plan
5.6
6.5
18
35
N05AD01
ATC
haloperidol; systemic
6.4
6.5
16
27
I95.1
ICD-10 Finland
Orthostatic hypotension
5.2
6.5
19
40
F06.7
ICD-10 Finland
Mild cognitive disorder
8.7
6.5
13
16
N02BE01
ATC
paracetamol; systemic, rectal
2.9
6.4
142
1116
F01.82
ICD-10 Finland
Other specified vascular dementia other additional symptoms, mainly hallucinations
+∞
6.3
6
*
F01.2
ICD-10 Finland
Subcortical vascular dementia
+∞
6.3
6
*
F01.0
ICD-10 Finland
Vascular dementia of acute onset
+∞
6.3
6
*
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
5.3
6.3
18
37
U04
ICPC
Incontinence urine
4.7
6.2
20
47
R41.3
ICD-10 Finland
Other amnesia
6.8
6.0
14
22
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3019309) Folate [Moles/volume] in Red Blood Cells
98
389
3.94
20.63
2.4
1.8
nmol/l
1052.5
1225.0
1.12
68
292
(3014271) Vancomycin [Susceptibility]
14
10
14.96
15.19
3.4
2.6
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
102
522
2.92
12.69
4.4
4.5
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
107
567
2.88
12.39
3.8
3.7
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
128
803
2.61
9.81
6.3
6.4
mmol/l
1.2
1.2
0.88
100
665
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
88
489
2.41
8.42
2.4
2.1
u/l
234.4
300.2
0.37
83
456
(3037467) Urinalysis macro (dipstick) panel - Urine
141
966
2.50
8.36
6.6
5.1
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
84
461
2.40
8.23
2.6
2.2
mg/l
2.8
3.2
1.06
58
399
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
111
694
2.32
7.98
2.8
2.1
pmol/l
84.6
91.7
0.66
55
375
(3015377) Calcium [Moles/volume] in Serum or Plasma
87
495
2.33
7.75
2.0
3.0
mmol/l
2.3
2.3
0.54
60
420
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
115
736
2.30
7.74
6.3
5.7
mmol/l
1.2
1.2
0.29
97
655
(3009542) Hematocrit [Volume Fraction] of Blood
142
1003
2.38
7.44
27.7
22.5
%
35.9
36.6
0.26
69
579
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
35
130
3.04
7.39
1.7
1.6
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
166
1269
2.69
7.14
28.2
19.8
mg/l
29.7
28.0
0.31
153
1095
(3032080) INR in Blood by Coagulation assay
108
712
2.10
6.31
16.1
12.9
inr
1.5
1.4
0.26
29
198
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
22
71
3.35
5.81
2.2
1.8
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
104
692
2.03
5.77
5.9
4.6
ng/l
40.1
50.7
0.50
87
565
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
149
1134
2.18
5.68
5.4
4.8
mu/l
2.1
2.1
0.15
126
981
(3024561) Albumin [Mass/volume] in Serum or Plasma
102
681
2.00
5.54
3.6
4.3
g/l
32.1
33.8
1.90
82
631
(3019550) Sodium [Moles/volume] in Serum or Plasma
166
1334
2.34
5.31
33.7
24.2
mmol/l
139.2
139.3
0.11
158
1297
(3023103) Potassium [Moles/volume] in Serum or Plasma
166
1335
2.34
5.28
33.7
24.4
mmol/l
4.0
4.0
0.19
158
1298
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
56
306
2.15
5.19
2.0
1.8
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
66
385
2.06
5.15
2.2
1.9
pmol/l
462.4
18211300.5
0.50
57
313
(3026361) Erythrocytes [#/volume] in Blood
166
1340
2.31
5.15
37.2
29.1
e12/l
4.2
4.3
1.43
154
1295
(3000963) Hemoglobin [Mass/volume] in Blood
166
1340
2.31
5.15
37.6
29.3
g/l
125.1
129.4
2.53
158
1310
(3024731) MCV [Entitic volume]
166
1340
2.31
5.15
37.2
29.1
fl
91.4
92.0
0.70
158
1315
(3007461) Platelets [#/volume] in Blood
166
1340
2.31
5.15
37.7
29.1
e9/l
231.4
231.8
0.03
157
1302
(3010813) Leukocytes [#/volume] in Blood
166
1340
2.31
5.15
37.2
29.1
e9/l
7.5
7.1
1.67
154
1293
(3035941) MCH [Entitic mass]
166
1340
2.31
5.15
37.0
29.0
pg
30.2
30.4
0.83
158
1315
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
9
9
10.39
5.08
3.0
2.6
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
19
61
3.33
5.06
2.3
1.5
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
122
892
1.92
4.84
7.3
4.8
mmol/l
7.6
6.9
1.90
111
842
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
97
660
1.90
4.78
3.6
2.8
u/l
59.8
58.9
0.03
85
603
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
108
773
1.85
4.44
3.8
5.4
umol/l
11.3
13.0
0.97
99
733
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
11
26
4.42
4.41
1.3
1.3
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
79
515
1.87
4.35
2.5
2.0
—
—
—
0
0
(3026782) Osmolality of Urine
62
374
1.95
4.31
3.7
3.6
mosm/kgh2o
541.8
536.8
0.07
51
327
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
14
41
3.59
4.27
1.3
1.5
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
14
41
3.59
4.27
1.3
1.5
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
11
27
4.25
4.22
1.1
1.3
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
122
919
1.82
4.13
4.1
3.9
pmol/l
15.4
15.4
0.03
99
805
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
82
549
1.83
4.10
2.5
2.3
nmol/l
77.4
79.2
0.22
66
485
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
25
106
2.55
4.10
1.8
1.4
—
—
—
0
0
(3019225) pH of Specimen
31
147
2.31
4.00
7.3
3.6
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
82
554
1.81
3.95
2.8
2.9
ug/l
122.9
162.4
1.16
68
500
(3007930) Methemoglobin/Hemoglobin.total in Blood
19
71
2.85
3.95
3.9
3.6
%
0.9
0.9
0.01
19
65
(40761511) CBC panel - Blood by Automated count
155
1271
1.93
3.86
27.8
19.0
—
—
—
0
0
(3020564) Creatinine [Moles/volume] in Serum or Plasma
158
1309
1.93
3.74
28.6
24.4
umol/l
92.9
91.0
0.26
158
1309
(3002030) Lymphocytes/100 leukocytes in Blood
89
625
1.76
3.71
5.0
6.1
%
20.3
23.5
2.38
74
575
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
86
600
1.75
3.65
4.6
3.9
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
87
614
1.73
3.52
5.7
6.0
%
8.9
9.0
0.20
74
571
(3022096) Basophils/100 leukocytes in Blood
85
599
1.72
3.44
4.2
5.8
%
0.5
0.5
0.03
73
553
(3047181) Lactate [Moles/volume] in Blood
13
42
3.24
3.43
5.1
5.1
mmol/l
1.4
1.6
0.25
13
37
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
134
1070
1.74
3.42
6.6
7.2
u/l
76.4
84.0
1.29
121
1015
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
18
71
2.68
3.40
3.6
3.5
%
1.5
1.5
0.04
18
66
(3044290) Cell count panel - Cerebral spinal fluid
7
10
7.20
3.39
1.0
1.4
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
46
271
1.90
3.36
29.8
33.7
inr
1.7
1.4
—
6
24
(3018010) Neutrophils/100 leukocytes in Blood
86
611
1.71
3.36
4.8
5.8
%
63.7
60.7
1.56
73
566
(3027456) Digoxin [Moles/volume] in Serum or Plasma
15
54
2.92
3.33
4.3
2.8
nmol/l
0.8
1.0
—
10
46
(3006504) Eosinophils/100 leukocytes in Blood
86
613
1.70
3.31
4.6
5.8
%
2.5
2.7
0.26
73
565
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
156
1308
1.83
3.29
10.5
11.4
u/l
28.7
23.0
0.40
144
1254
(3013707) Erythrocyte sedimentation rate by Westergren method
127
1006
1.70
3.27
4.7
4.4
mm/h
17.6
17.3
0.05
113
917
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
53
330
1.82
3.26
4.3
4.2
ng/l
155.1
172.3
0.07
45
302
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
19
80
2.52
3.17
1.6
1.8
ug/l
3.3
4.5
0.10
12
70
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
24
113
2.27
3.15
3.8
3.9
mmol/l
3.4
1.5
1.66
14
86
(3006315) Basophils [#/volume] in Blood
90
657
1.66
3.12
3.7
5.5
e9/l
0.0
0.0
0.13
71
555
(3027945) Reticulocytes/100 erythrocytes in Blood
42
246
1.89
3.11
1.6
2.3
%
1.8
1.8
0.03
28
226
(3003338) MCHC [Mass/volume]
121
955
1.66
3.08
30.6
27.8
g/l
329.4
330.0
0.26
114
948
(3012544) pH of Venous blood
34
186
1.99
3.07
2.6
3.8
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
92
678
1.65
3.06
4.0
5.7
e9/l
0.2
0.2
0.31
72
582
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
15
58
2.71
2.95
1.4
1.2
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
49
308
1.78
2.90
2.7
3.0
mmol/l
2.5
2.5
0.10
29
262
(3017704) Immunofixation for Urine
6
9
6.83
2.88
1.2
1.0
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
88
651
1.62
2.83
3.6
5.5
e9/l
0.7
0.6
1.44
69
548
(3019198) Lymphocytes [#/volume] in Blood
90
670
1.62
2.82
3.8
5.7
e9/l
1.6
1.7
0.80
71
581
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
57
378
1.71
2.79
2.5
2.5
u/l
28.9
35.7
1.17
52
364
(3023520) Reticulocytes [#/volume] in Blood
31
171
1.96
2.73
2.2
2.3
e9/l
60.6
66.7
0.46
23
137
(3044927) Protein electrophoresis panel - Urine
9
24
3.87
2.70
1.2
1.1
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
12
43
2.90
2.69
1.0
4.7
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
31
172
1.95
2.69
2.9
2.7
ug/l
4.1
6.5
0.66
16
154
(3018418) pH of Serum or Plasma
71
506
1.62
2.62
3.2
4.1
ph
7.4
7.4
0.06
16
100
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
7
15
4.79
2.62
1.3
1.3
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
24
123
2.08
2.58
3.8
3.8
kpa
5.4
5.1
0.64
19
117
(3003458) Phosphate [Moles/volume] in Serum or Plasma
39
237
1.80
2.57
2.9
4.9
mmol/l
1.0
1.1
0.07
32
218
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
7
16
4.49
2.49
1.4
1.3
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
7
16
4.49
2.49
1.4
1.3
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
40
248
1.76
2.46
1.5
2.8
mmol/l
0.8
0.8
0.34
29
225
(3004588) Protein electrophoresis panel - Serum or Plasma
26
140
1.98
2.46
1.7
2.5
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
65
462
1.60
2.40
4.1
5.3
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
8
22
3.74
2.39
2.3
1.5
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
72
525
1.58
2.38
4.1
4.0
e6/l
91.1
216.5
0.47
57
421
(3013650) Neutrophils [#/volume] in Blood by Automated count
98
774
1.51
2.23
5.1
8.3
e9/l
5.2
4.6
1.22
76
667
(3000012) Reticulocyte production index
5
9
5.66
2.22
1.0
1.3
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
13
55
2.46
2.17
2.5
2.7
pmol/l
3.8
4.1
—
5
48
(3002032) Base excess in Venous blood by calculation
31
185
1.80
2.17
2.5
3.9
mmol/l
1.4
1.9
0.33
24
146
(3025941) Bacteria identified in Stool by Culture
16
75
2.23
2.15
1.4
1.3
—
—
—
0
0
(1616796) Gas panel - Central venous blood
11
43
2.65
2.13
2.7
3.8
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
65
474
1.55
2.12
2.3
3.0
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
55
389
1.57
2.04
2.8
3.2
e6/l
7.7
4.4
1.03
46
346
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
82
635
1.49
2.00
5.4
4.6
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
6
16
3.83
1.95
1.5
1.3
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
6
16
3.83
1.95
1.5
1.3
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
61
446
1.53
1.95
4.1
3.8
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
16
79
2.11
1.91
4.4
8.7
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
76
584
1.48
1.91
4.8
4.5
e6/l
192.8
228.5
0.08
56
451
(3036481) Cortisol [Moles/volume] in Serum or Plasma
20
108
1.94
1.89
2.0
1.7
nmol/l
425.4
405.6
0.12
14
99
(3008152) Bicarbonate [Moles/volume] in Arterial blood
21
116
1.90
1.87
6.5
6.2
mmol/l
23.3
23.7
0.18
21
108
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
24
139
1.82
1.85
2.5
3.8
ng/l
70.2
92.3
1.01
18
125
(3005988) Vibrio sp identified in Specimen by Organism specific culture
6
17
3.60
1.85
1.5
1.2
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
64
480
1.49
1.80
4.0
3.8
e6/l
0.5
0.5
0.05
49
379
(3003396) Base excess in Arterial blood by calculation
32
204
1.68
1.79
4.5
6.3
mmol/l
0.9
1.3
0.30
19
157
(3022313) Gas panel - Capillary blood
16
82
2.03
1.75
4.1
4.0
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
40
273
1.58
1.72
1.7
2.4
g/l
2.3
2.2
0.27
29
249
(3024928) Oxygen saturation in Venous blood
10
42
2.45
1.70
1.7
2.3
—
—
—
0
0
(3013512) EKG study
62
468
1.47
1.67
5.6
5.3
—
—
—
0
0
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
31
201
1.64
1.63
4.2
6.3
kpa
4.6
5.0
1.69
26
192
(3022948) Iron [Moles/volume] in Serum or Plasma
43
302
1.54
1.63
1.7
2.4
umol/l
9.8
11.1
0.62
32
274
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
136
1188
1.44
1.63
7.9
7.2
mmol/mol
47.0
42.4
2.95
117
1074
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
17
92
1.93
1.61
3.0
2.5
—
—
—
0
0
(3027801) Oxygen [Partial pressure] in Arterial blood
31
202
1.63
1.60
4.2
6.3
kpa
9.3
11.0
3.17
26
194
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
25
154
1.71
1.59
1.5
2.3
umol/l
5.6
11.4
2.40
18
130
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
19
108
1.84
1.57
1.5
1.6
g/l
1.4
1.7
0.72
11
96
(3041096) Erythrocytes [Presence] in Urine by Automated
50
368
1.48
1.52
5.9
5.1
—
—
—
0
0
(3022621) pH of Urine by Test strip
17
95
1.86
1.48
5.1
4.3
—
—
—
0
0
(3028271) Lactate [Moles/volume] in Capillary blood
7
28
2.55
1.46
3.3
2.1
mmol/l
3.6
1.6
—
7
28
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
132
1163
1.39
1.40
27.2
19.5
ml/min/173m2
62.1
65.5
1.10
108
967
(3021960) Folate [Moles/volume] in Serum or Plasma
56
434
1.40
1.29
1.9
1.7
nmol/l
19.2
20.8
0.23
49
368
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
8
36
2.27
1.26
1.0
1.4
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
9
45
2.05
1.25
1.1
1.3
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
5
19
2.67
1.22
1.2
1.7
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
8
38
2.15
1.20
1.0
1.1
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
26
176
1.55
1.17
5.4
4.0
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
8
41
1.99
1.10
2.1
2.5
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
7
32
2.23
1.09
1.0
1.4
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
82
691
1.31
1.08
5.0
5.1
estimate
0.0
0.0
0.00
17
136
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
135
1220
1.32
1.06
5.0
5.6
mmol/l
6.6
6.2
1.38
111
1067
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
9
160
0.54
1.03
1.1
1.3
—
12.8
—
0
50
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
74
620
1.30
1.01
5.2
5.7
ug/l
2.1
4.8
1.43
60
541
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
45
351
1.36
0.99
2.2
3.0
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
30
218
1.44
0.99
1.8
1.7
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
30
219
1.43
0.96
1.8
1.8
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
6
27
2.26
0.94
2.8
3.1
e9/l
6.9
5.5
—
6
27
(3000991) Gas panel - Venous blood
23
160
1.49
0.94
2.4
7.6
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
6
28
2.18
0.92
3.2
3.8
%
67.3
64.7
—
6
28
(3019230) Fractional oxyhemoglobin in Venous blood
6
28
2.18
0.92
1.3
2.0
%
57.7
57.5
—
6
28
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
36
275
1.38
0.91
4.4
3.4
e6/l
1.3
2.5
0.74
18
161
(3019060) Gas panel - Arterial blood
19
128
1.53
0.90
5.5
3.5
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
80
688
1.27
0.87
4.9
4.9
estimate
0.0
0.0
0.00
18
144
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
25
180
1.44
0.87
4.9
5.2
%
33.6
33.6
0.01
15
112
(3027315) Oxygen [Partial pressure] in Blood
8
44
1.85
0.87
6.5
3.6
kpa
7.0
7.7
—
8
44
(3013290) Carbon dioxide [Partial pressure] in Blood
8
44
1.85
0.87
6.5
3.6
kpa
4.9
5.0
—
8
44
(3012501) Base excess in Blood by calculation
8
44
1.85
0.87
6.5
3.6
mmol/l
2.4
2.9
—
8
28
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
34
261
1.36
0.83
2.0
2.5
%
20.1
20.4
0.05
20
229
(36660697) Celiac disease serology panel - Serum
11
66
1.70
0.80
1.3
1.2
—
—
—
0
0
(4010399)
5
98
0.50
0.80
1.2
1.4
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
26
192
1.41
0.80
1.4
1.3
g/l
4.5
2.6
—
9
117
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
0
25
0.00
0.79
0.0
2.3
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
0
26
0.00
0.79
0.0
1.1
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
133
1225
1.25
0.76
4.5
5.6
mmol/l
2.1
2.4
2.82
114
1082
(4035726)
8
135
0.58
0.76
1.0
1.4
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
14
92
1.56
0.74
4.0
6.7
mmol/l
25.3
24.7
0.21
14
92
(3052851) Hemolysis interference index of Serum or Plasma
9
56
1.63
0.73
5.8
4.6
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
7
40
1.78
0.72
2.4
1.7
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
20
144
1.43
0.71
1.8
2.0
g/l
0.2
0.2
0.55
15
134
(3017732) Neutrophils [#/volume] in Blood
12
77
1.59
0.70
2.7
3.1
e9/l
4.4
4.1
—
5
53
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
5
27
1.87
0.69
1.0
1.4
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
5
27
1.87
0.69
1.6
1.7
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
20
146
1.41
0.67
3.1
4.1
mmol/l
1.2
1.2
0.21
20
130
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
5
29
1.74
0.64
1.0
1.3
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
21
156
1.39
0.64
5.5
7.4
g/l
119.6
117.1
0.23
21
150
(3020630) Protein [Mass/volume] in Serum or Plasma
22
165
1.37
0.63
1.9
2.6
g/l
64.6
65.0
0.06
16
149
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
57
489
1.23
0.62
4.6
4.8
%
22.8
22.1
0.10
24
273
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
24
184
1.35
0.61
14.0
8.7
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
8
51
1.59
0.61
2.1
2.8
kpa
7.3
8.0
—
8
45
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
0
20
0.00
0.60
0.0
1.2
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
13
89
1.49
0.59
1.7
3.1
—
—
—
0
0
(3010421) pH of Blood
8
53
1.53
0.59
6.5
3.7
ph
7.4
7.4
—
8
44
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
41
341
1.25
0.59
3.8
3.2
ug/l
0.7
0.9
1.02
26
244
(3021589) Normoblasts [#/volume] in Blood
65
569
1.21
0.58
11.9
11.6
e9/l
0.0
0.0
0.62
51
461
(3000492) Spirometry study
5
87
0.56
0.57
1.0
1.6
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
30
241
1.29
0.56
3.0
5.3
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
37
306
1.26
0.56
1.3
1.7
mg/l
2.3
1.5
0.78
30
252
(3015235) Bicarbonate [Moles/volume] in Capillary blood
9
60
1.52
0.55
2.2
3.0
mmol/l
25.2
24.5
—
9
50
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
6
38
1.60
0.55
1.3
1.0
—
84.9
—
0
9
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
6
97
0.61
0.53
1.0
1.2
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
27
330
0.79
0.50
3.1
4.6
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
121
1131
1.17
0.49
3.6
4.4
mmol/l
1.2
1.2
0.18
101
986
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
73
656
1.18
0.48
3.7
3.4
ng/l
2874.2
2405.4
0.29
58
570
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
124
1163
1.17
0.48
4.1
4.9
mmol/l
1.3
1.4
1.29
104
1024
(42529406) Shigella sp [Presence] in Stool by Culture
7
49
1.44
0.46
1.4
1.1
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
7
49
1.44
0.46
1.4
1.1
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
7
49
1.44
0.46
1.4
1.1
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
76
688
1.17
0.46
7.3
6.9
estimate
0.0
0.0
0.00
18
137
(40761536) Microorganisms panel - Urine sediment
16
121
1.35
0.46
6.4
4.8
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
7
50
1.41
0.45
1.4
1.2
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
10
69
1.47
0.45
1.0
1.2
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
125
1178
1.16
0.44
4.0
4.9
mmol/l
3.9
4.2
2.41
105
1051
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
60
536
1.17
0.42
5.7
5.6
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
15
114
1.34
0.42
2.0
1.6
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
11
79
1.41
0.41
2.1
2.8
g/l
12.2
10.4
—
6
68
(3033705) Calcium.ionized [Moles/volume] in Venous blood
5
33
1.53
0.41
2.0
2.8
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
0
16
0.00
0.41
0.0
1.4
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
5
34
1.48
0.40
1.6
1.6
—
—
—
0
0
(1002224) Polysomnography panel
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
(3002256) Pathology report gross observation
13
170
0.75
0.40
1.2
1.4
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
27
225
1.23
0.39
1.9
3.4
u/l
271.6
248.8
0.28
21
212
(3042111) Morphology [Interpretation] in Bone marrow Narrative
5
37
1.36
0.37
1.2
1.5
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
6
42
1.44
0.36
1.0
1.3
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
44
389
1.17
0.36
2.5
3.1
umol/l
404.3
6988.6
1.92
33
323
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
11
82
1.36
0.35
2.1
2.8
—
—
—
0
0
(4034850)
6
44
1.37
0.34
23.2
16.2
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
48
533
0.87
0.33
2.1
2.5
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
22
184
1.22
0.32
1.8
1.8
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
51
461
1.14
0.31
3.8
3.2
mg/l
1317.0
196.3
0.42
34
314
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
7
53
1.33
0.31
1.9
1.4
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
35
309
1.16
0.29
4.9
5.6
kg/l
1.0
1.0
0.06
12
39
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
33
290
1.16
0.29
4.2
3.1
e6/l
0.8
1.3
1.05
15
176
(3020682) Albumin/Creatinine [Ratio] in Urine
54
493
1.13
0.29
4.3
4.0
mg/mmol
13.6
11.1
0.19
32
338
(1761482) Bacteria [#/volume] in Urine by Culture
8
65
1.24
0.27
11.0
6.1
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
6
83
0.71
0.24
1.0
1.2
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
32
286
1.14
0.23
1.4
1.2
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
26
294
0.87
0.23
3.0
4.0
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(4281824)
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
0
11
0.00
0.21
0.0
2.7
—
156.9
—
0
11
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(44806420)
0
11
0.00
0.21
0.0
2.6
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
50
463
1.11
0.21
3.8
3.2
mmol/l
6.2
6.6
0.31
36
384
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
0
12
0.00
0.21
0.0
1.6
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
0
13
0.00
0.21
0.0
3.8
—
—
—
0
0
(3008898) HLA-B27 [Presence]
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
6
52
1.16
0.19
3.2
2.3
—
—
—
0
0
(40758558) Short blood count panel - Blood
32
350
0.90
0.18
2.5
6.2
—
—
—
0
0
(3022145) Colonoscopy Study observation
15
131
1.16
0.15
1.4
1.2
—
—
—
0
0
(3044889) 12 lead EKG panel
94
908
1.07
0.14
4.8
4.9
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
22
237
0.92
0.09
3.0
2.0
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
11
97
1.14
0.09
1.0
1.4
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
6
54
1.11
0.09
2.0
1.5
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
5
62
0.80
0.08
5.0
2.3
—
—
—
0
0
(3020891) Body temperature
6
72
0.83
0.08
7.8
4.2
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
7
84
0.83
0.07
1.0
1.3
—
—
—
0
0
(40761535) Cells panel - Urine sediment
15
139
1.09
0.05
5.9
3.9
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
19
180
1.06
0.04
1.3
1.3
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
40
392
1.03
0.01
4.9
5.2
estimate
0.0
0.0
0.00
16
131
(3000494) Fungus identified in Specimen by Culture
15
147
1.02
0.00
1.5
1.4
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
10
98
1.02
0.00
9.3
5.5
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
8
80
1.00
0.00
1.0
1.3
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
8
88
0.91
0.00
2.1
1.6
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
0
6
0.00
0.00
0.0
3.2
—
—
—
0
0
(3029634) Reagin Ab [Titer] in Serum by VDRL
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
0
6
0.00
0.00
0.0
1.5
—
6.6
—
0
6
(3013005) Retinol [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.5
—
2.2
—
0
6
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.5
—
30.9
—
0
8
(3012565) Volume of 24 hour Urine
0
5
0.00
0.00
0.0
2.4
—
2550.0
—
0
5
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.8
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
0
8
0.00
0.00
0.0
1.8
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(40768441) Liver Pathology biopsy report
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013727) Leukocytes other/100 leukocytes in Blood
0
9
0.00
0.00
0.0
5.0
—
52.8
—
0
9
(4268621)
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
2.2
—
83.5
—
0
6
(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum
0
9
0.00
0.00
0.0
1.2
—
30.5
—
0
9
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011544) Albumin [Mass/volume] in Pleural fluid
0
8
0.00
0.00
0.0
1.0
—
17.8
—
0
8
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma
0
7
0.00
-0.00
0.0
1.0
—
86.1
—
0
7
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
0
7
0.00
-0.00
0.0
1.3
—
92.1
—
0
7
(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma
0
7
0.00
-0.00
0.0
1.0
—
21.9
—
0
7
(3018851) Theophylline [Moles/volume] in Serum or Plasma
0
7
0.00
-0.00
0.0
1.0
—
39.0
—
0
7
Mortality – FinRegistry
↥Association
Association between endpoint VD_O and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| VD_O | 2.601 [2.03, 3.34] | < 0.001 |
| Birth year | 0.99 [0.98, 1.0] | 0.024 |
During the follow-up period (1.1.1998 — 31.12.2019), 713 out of 1011 females with VD_O died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| VD_O | 3.589 [2.45, 5.26] | < 0.001 |
| Birth year | 0.986 [0.98, 0.99] | 0.003 |
During the follow-up period (1.1.1998 — 31.12.2019), 514 out of 719 males with VD_O died.
Mortality risk
Mortality risk for people of age
years, who have VD_O.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.244% | 0.683% |
| 5 | 1.3% | 3.886% |
| 10 | 3.422% | 9.403% |
| 15 | 6.283% | 17.236% |
| 20 | 10.778% | 28.535% |
Relationships between endpoints
↥Index endpoint: VD_O – Vascular dementia (other)
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data